Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» It's All About the Future for Amylin
It's All About the Future for Amylin
It's All About the Future for Amylin
Submitted by
admin
on July 22, 2010 - 3:49pm
Source:
Motley Fool
News Tags:
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
Headline:
It's All About the Future for Amylin
Do Not Allow Advertisers to Use My Personal information
